According to a 3 February press release, EssilorLuxottica received simultaneous clearance from the US Food and Drug ...

EssilorLuxottica said on Monday it received a green light from the U.S. Food and Drug Administration (FDA) for its ...

Read here for an analysis of EssilorLuxottica's market leadership, growth potential, and future value drivers, with a BUY ...

EssilorLuxottica receives FDA clearance and EU certifications for Nuance Audio, making it available to consumers in the U.S. and Europe Paris, France (3 February 2025) – EssilorLuxottica announced ...

Recent health news highlights various developments, including EssilorLuxottica's FDA clearance for Nuance audio glasses, WHO ...

Investing.com -- RBC Capital Markets has upgraded EssilorLuxottica (EPA: ESLX) to "outperform," citing strong fundamentals ...

Nuance Audio showcased its glasses with built-in hearing aids at CES 2025. Now that the product is FDA-approved, it will be available in the US in the coming months.

RBC Capital upgraded EssilorLuxottica (ESLOY) to Outperform from Sector Perform with a price target of EUR 290, up from EUR 220. The firm cites ...

Recent health news includes EssilorLuxottica's new FDA-approved Nuance audio glasses, Baxter's CEO José Almeida retiring, Pfizer facing challenges with COVID-related revenue, WHO budget cuts amid U.S ...

In a significant advancement in hearing and vision solutions, EssilorLuxottica has announced that its Nuance Audio Glasses ...

EssilorLuxottica SA (0OMK – Research Report) received a Buy rating and a €290.00 price target from RBC Capital analyst Piral Dadhania today.